Naoya Miura

机构：Tokai University, Tokai University Hospital, Okinawa Prefectural Chubu Hospital · ORCID：0000-0003-1292-5177

发表论文 55 篇 · 总被引 1192 次 · h-index 17

代表论文

• Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with a vitamin E scaffold and the KALA peptide for use as an ex vivo dendritic cell-based cancer vaccine (2019 · Journal of Controlled Release · 被引 96)
• Outcome of extracorporeal membrane oxygenation use in severe accidental hypothermia with cardiac arrest and circulatory instability: A multicentre, prospective, observational study in Japan (ICE-CRASH study) (2022 · Resuscitation · 被引 58)
• Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry (2019 · Journal of the American Heart Association · 被引 55)
• Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects (2017 · Molecular Therapy · 被引 42)
• Development of a mouse model for the visual and quantitative assessment of lymphatic trafficking and function by in vivo imaging (2018 · Scientific Reports · 被引 38)
• DNA-loaded nano-adjuvant formed with a vitamin E-scaffold intracellular environmentally-responsive lipid-like material for cancer immunotherapy (2018 · Nanomedicine Nanotechnology Biology and Medicine · 被引 37)